Showing all 4 results
Drotaverine Injection
FreeProduct Composition & Strength
We supply this product as a Sterile Solution in Amber Glass Ampoules.
Active Ingredient Strength Volume Drotaverine Hydrochloride USP/BP 40 mg 2 ml Ampoule (20 mg/ml) Excipients Sodium Metabisulfite Antioxidant *Pack Sizes: Tray of 5 Ampoules, 10 Ampoules, or 50 Ampoules.
Hyoscine Butylbromide Injection
FreeProduct Composition & Strength
We supply this product as a Sterile Solution in Glass Ampoules.
Active Ingredient Strength Volume Hyoscine Butylbromide USP/BP 20 mg 1 ml Ampoule (Standard Dose) Excipients Sodium Chloride / Water for Injection Isotonic Solution *Pack Sizes: Tray of 5 Ampoules, 10 Ampoules, or 100 Ampoules.
Hyoscine Butylbromide Tablets
FreeProduct Composition & Strength
We supply this product as Sugar Coated Tablets or Film Coated Tablets. The coating is essential to mask the naturally bitter taste of the active ingredient and ensure patient compliance.
Active Ingredient Strength (Standard) Therapeutic Role Hyoscine Butylbromide BP/USP 10 mg Muscarinic Antagonist (Antispasmodic) Excipients Q.S. Calcium Hydrogen Phosphate / Maize Starch Stabilizing Core Matrix Coating Agent Q.S. Sucrose / Talc / Acacia Traditional Sugar Coating Mebeverine Tablet
FreeProduct Composition & Available Formats
We supply Mebeverine Hydrochloride in both rapid-acting immediate-release and advanced continuous-release configurations to accommodate customized patient compliance tracking.
Active Ingredient Monograph Available Strengths Formulation Matrix Delivery System Primary Clinical Application Mebeverine Hydrochloride IP / BP / USP 135 mg Oral Solid Immediate-Release Film-Coated Tablet Targeted Acute Dosing: Fast-acting formulation designed for standard three-times-daily administration prior to localized food triggers. Mebeverine Hydrochloride IP / BP / USP 200 mg SR Sustained-Release Hydrophilic Polymer Matrix Tablet / Capsule Continuous 24-Hour Coverage: Premium, once- or twice-daily formulation engineered to release active molecules continuously, eliminating nocturnal spikes and maximizing compliance.
